Implications of the differing roles of the β1 and β3 transmembrane and cytoplasmic domains for integrin function

  1. Zhenwei Lu
  2. Sijo Mathew
  3. Jiang Chen
  4. Arina Hadziselimovic
  5. Riya Palamuttam
  6. Billy G Hudson
  7. Reinhard Faessler
  8. Ambra Pozzi
  9. Charles R Sanders  Is a corresponding author
  10. Roy Zent  Is a corresponding author
  1. Vanderbilt University Medical Center, United States
  2. Vanderbilt Medical Center, United States
  3. Virginia Tech, United States
  4. Max Planck Institute of Biochemistry, Germany

Abstract

Integrins are transmembrane receptors composed of α and β subunits. Although most integrins contain β1, canonical activation mechanisms are based on studies of the platelet integrin, αIIbβ3. Its inactive conformation is characterized by association of the αIIb transmembrane and cytosolic domain (TM/CT) with a tilted β3 TM/CT that leads to activation when disrupted. We show significant structural differences between β1 and β3 TM/CT in bicelles. Moreover, the 'snorkeling' lysine at the TM/CT interface of β subunits, previously proposed to regulate αIIbβ3 activation by ion pairing with nearby lipids, plays opposite roles in β1 and β3 integrin function and in neither case is responsible for TM tilt. Affinities ranging from almost no interaction to the relatively high avidity that characterizes αIIbβ3 exist between various α subunits and β1 TM/CTs. The αIIbβ3-based canonical model for the roles of the TM/CT in integrin activation and function clearly does not extend to all mammalian integrins.

Article and author information

Author details

  1. Zhenwei Lu

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  2. Sijo Mathew

    Division of Nephrology, Department of Medicine, Vanderbilt Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  3. Jiang Chen

    Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, United States
    Competing interests
    No competing interests declared.
  4. Arina Hadziselimovic

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  5. Riya Palamuttam

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  6. Billy G Hudson

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  7. Reinhard Faessler

    Department of Molecular Medicine, Max Planck Institute of Biochemistry, Martinsried, Germany
    Competing interests
    Reinhard Faessler, Reviewing editor, eLife.
  8. Ambra Pozzi

    Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    Ambra Pozzi, Reviewing editor, eLife.
  9. Charles R Sanders

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    For correspondence
    chuck.sanders@vanderbilt.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2046-2862
  10. Roy Zent

    Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States
    For correspondence
    roy.zent@vanderbilt.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2983-8133

Funding

Veterans Affairs San Diego Healthcare System

  • Ambra Pozzi
  • Roy Zent

National Institutes of Health

  • Billy G Hudson
  • Ambra Pozzi
  • Charles R Sanders
  • Roy Zent

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Lu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,996
    views
  • 525
    downloads
  • 28
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zhenwei Lu
  2. Sijo Mathew
  3. Jiang Chen
  4. Arina Hadziselimovic
  5. Riya Palamuttam
  6. Billy G Hudson
  7. Reinhard Faessler
  8. Ambra Pozzi
  9. Charles R Sanders
  10. Roy Zent
(2016)
Implications of the differing roles of the β1 and β3 transmembrane and cytoplasmic domains for integrin function
eLife 5:e18633.
https://doi.org/10.7554/eLife.18633

Share this article

https://doi.org/10.7554/eLife.18633

Further reading

    1. Biochemistry and Chemical Biology
    Jianheng Fox Liu, Ben R Hawley ... Samie R Jaffrey
    Tools and Resources

    N 6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m6Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Eva Herdering, Tristan Reif-Trauttmansdorff ... Ruth Anne Schmitz
    Research Article

    Glutamine synthetases (GS) are central enzymes essential for the nitrogen metabolism across all domains of life. Consequently, they have been extensively studied for more than half a century. Based on the ATP-dependent ammonium assimilation generating glutamine, GS expression and activity are strictly regulated in all organisms. In the methanogenic archaeon Methanosarcina mazei, it has been shown that the metabolite 2-oxoglutarate (2-OG) directly induces the GS activity. Besides, modulation of the activity by interaction with small proteins (GlnK1 and sP26) has been reported. Here, we show that the strong activation of M. mazei GS (GlnA1) by 2-OG is based on the 2-OG dependent dodecamer assembly of GlnA1 by using mass photometry (MP) and single particle cryo-electron microscopy (cryo-EM) analysis of purified strep-tagged GlnA1. The dodecamer assembly from dimers occurred without any detectable intermediate oligomeric state and was not affected in the presence of GlnK1. The 2.39 Å cryo-EM structure of the dodecameric complex in the presence of 12.5 mM 2-OG demonstrated that 2-OG is binding between two monomers. Thereby, 2-OG appears to induce the dodecameric assembly in a cooperative way. Furthermore, the active site is primed by an allosteric interaction cascade caused by 2-OG-binding towards an adaption of an open active state conformation. In the presence of additional glutamine, strong feedback inhibition of GS activity was observed. Since glutamine dependent disassembly of the dodecamer was excluded by MP, feedback inhibition most likely relies on the binding of glutamine to the catalytic site. Based on our findings, we propose that under nitrogen limitation the induction of M. mazei GS into a catalytically active dodecamer is not affected by GlnK1 and crucially depends on the presence of 2-OG.